VLP


Also found in: Dictionary, Acronyms, Encyclopedia.

VHLL

A gene on chromosome 1q22 that encodes a protein which functions as a dominant-negative VHL (protein) to protect HIFalpha.

VLP

Virus-like particles, see there.
References in periodicals archive ?
Recombinant VLP systems can be arranged to gain more functionalities to present drugs, imaging reagents, antigenic epitopes of a corresponding virus or another disease-associated antigen and specific targeting peptides to the internal and external surfaces of the particle.
Based results of second axis (20.5% of explained variance) showed a group of variables integrated by NID, nitrogen to phosphorus ratio (N/P), BB and BA that were positively correlated, and another group in which the VBR, DO and VLP were the most negatively correlated with this component (Fig.
So the criteria for use of VLP differed in each institution.
For the production of HPV16 L1 VLP, 1 x [10.sup.9] sf9 cells were grown at 27 [degrees]C in Grace's insect medium (Sigma) supplemented with 10% fetal calf serum, gentamycin and amphotericin.
A simple IP camera is monitoring traffic flow, capturing frames, where the most visible VLP. Of the frames found VLP and sent VLP picture of the network.
"With datacenters demanding more compute capability per unit volume, our 16GB VLP memory module enables OEM customers to provide Storage Bridge Bay and Blade servers with greater memory density using mainstream 2Gb DRAM."
Medicago is committed to providing highly effective and affordable vaccines based on proprietary Virus-Like Particle (VLP) and manufacturing technologies.
VLP vaccines, with many varieties in early-stage development, show promise of being both low cost and high yield, with a rapid (12-week) production cycle, he said.
He discussed three promising types of influenza vaccines: live attenuated influenza viruses (LAIV), recombinant viruslike particles (VLP), and plant-based production of vaccines.
The young leaders from Scotswood, Newcastle, are part of the NCB Volunteer Leadership Programme (VLP).
An experimental vaccine developed using non-infectious virus-like particles (VLP) has protected macaques and mice against chikungunya virus, a mosquito-borne pathogen that has infected millions of people in Africa and Asia and causes debilitating pain, researchers at the National Institutes of Health have found.
Background & objective: Recombinant DNA technology allows expression of the human papillomavirus (HPV) major capsid protein (LI) in heterologous expression systems and the recombinant protein self assembles to virus-like particles (VLP).